Detalhe da pesquisa
1.
First-in-Human Phase 1 Study of ES-072, an Oral Mutant-Selective EGFR T790M Inhibitor, in Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 21(6): 509-519.e1, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32800640
2.
Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study.
Orphanet J Rare Dis
; 13(1): 34, 2018 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29458386